An N-terminally truncated third progesterone receptor protein, PR(C), forms heterodimers with PR(B) but interferes in PR(B)-DNA binding

Journal of Steroid Biochemistry and Molecular Biology

Volumn 62, Issue 4, 1997, Pages 287-297

  Wei, Lisa L ^a,b   Norris, Brian M ^a   Baker, Cathryn J ^a  

^a GEORGETOWN UNIVERSITY   (United States)

^b Department of Physiology ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROGESTERONE RECEPTOR; RECEPTOR PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; AUTOREGULATION; BACULOVIRUS; BINDING SITE; CONTROLLED STUDY; DNA BINDING; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IN VITRO STUDY; PROTEIN ANALYSIS; PROTEIN VARIANT; RECEPTOR BINDING;

UNIDENTIFIED BACULOVIRUS;

EID: 0030816914     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-0760(97)00044-7     Document Type: Article

References (36)

1. Wei L. L., Sheridan P. L., Krett N. L., Francis M. D., Toft D. O., Edwards D. P. and Horwitz K. B., Immunologic analysis of human breast cancer progesterone receptors. 2. Structure, phosphorylation, and processing. Biochemistry 26 (1987) 6262-6272.
2. Wei L. L. and Horwitz K. B., The structure of progesterone receptors. Steroids 46 (1985) 677-695.
3. Evans R. M., The steroid and thyroid hormone receptor super-family. Science 240 (1988) 889-895.
4. Tsai M. J. and O'Malley B. W., Molecular mechanisms of action of steroid/thyroid receptor super-family members. Annu. Rev. Biochem. 63 (1994) 451-486.
5. Kumar V. and Chambon P., The estrogen receptor binds tightly to its responsive element as a ligand-induced homodimer. Cell 55 (1988) 145-156.
6. Tsai S. Y., Carlstedt-Duke J., Weigel N. L., Dahlman K., Gustafsson J. A., Tsai M. J. and O'Malley B. W., Molecular interactions of steroid hormone receptor with its enhancer element: evidence for receptor dimer formation. Cell 55 (1988) 361-369.
7. Wrange O., Eriksson P. and Perlmann T., The purified activated glucocorticoid receptor is a homodimer. J. Biol. Chem. 264 (1989) 5253-5259.
8. Conneely O. M., Kettelberger D. M., Tsai M. J., Schrader W. T. and O'Malley B. W., The chicken progesterone receptor A and B isoforms are products of an alternate translation initiation event. J. Biol. Chem. 264 (1989) 14062-14064.
9. Kastner P., Krust A., Turcotte B., Stropp U., Tora L., Gronemeyer H. and Chambon P., Two distinct estrogen-regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B. EMBO J. 9 (1990) 1603-1614.
10. Krett N. L., Wei L. L., Francis M. D., Nordeen S. K., Gordon D. F., Wood W. M. and Horwitz K. B., Human progesterone A-receptors can be synthesized intracellularly and are biologically functional. Biochem. Biophys. Res. Commun. 157 (1988) 278-285.
11. Tung L., Mohamed M. K., Hoeffler J. P., Takimoto G. S. and Horwitz K. B., Antagonist-occupied human progesterone B-receptors activate transcription without binding to progesterone response elements and are dominantly inhibited by A-receptors [see comments]. Mol. Endocrinol. 7 (1993) 1256-1265.
12. Vegeto E., Shahbaz M. M., Wen D. X., Goldman M. E., O'Malley B. W. and McDonnell D. P., Human progesterone receptor A form is a cell-and promoter-specific represser of human progesterone receptor B function [see comments]. Mol. Endocrinol. 7 (1993) 1244-1255.
13. Wen D. X., Xu Y. F., Mais D. E., Goldman M. E. and McDonnell D. P., The A and B isoforms of the human progesterone receptor operate through distinct signaling pathways within target cells. Mol. Cell. Biol. 14 (1994) 8356-8364.
14. Wei L. L., Krett N. L., Francis M. D., Gordon D. F., Wood W. M., O'Malley B. W. and Horwitz K. B., Multiple human progesterone receptor messenger ribonucleic acids and their autoregulation by progestin agonists and antagonists in breast cancer cells. Mol. Endocrinol 2 (1988) 62-72.
15. Wei L. L. and Miner R., Evidence for the existence of a third progesterone receptor protein in human breast cancer cell line T47D. Cancer Res. 54 (1994) 340-343.
16. Weigel N. L., Beck C. A., Estes P. A., Prendergast P., Altmann M., Christensen K. and Edwards D. P., Ligands induce conformational changes in the carboxyl-terminus of progesterone receptors which are detected by a site-directed antipeptide monoclonal antibody. Mol. Endocrinol. 6 (1992) 1585-1597.
17. Wei L. L., Gonzalez-Aller C., Wood W. M., Miller L. A. and Horwitz K. B., 5′-heterogeneity in human progesterone receptor transcripts predicts a new amino-terminal truncated "C"-receptor and unique A-receptor messages. Mol. Endocrinol. 4 (1990) 1833-1840.
18. C, enhances progestin-induced transcriptional activity. Mol. Endocrinol. 10 (1996) 1379-1387.
19. Michna H., Schneider M. R., Nishino Y. and el Etreby M. F., Antitumor activity of the antiprogestins ZK 98.299 and RU 38.486 in hormone dependent rat and mouse mammary tumors: mechanistic studies. Breast Cancer Res. Treat. 14 (1989) 275-288.
20. Edwards D. P., De Marzo A. M., Onate S. A., Beck C. A., Estes P. A. and Nordeen S. K., Mechanisms controlling steroid receptor binding to specific DNA sequences. Steroids 56 (1991) 271-278.
21. Allan G. F., Leng X., Tsai S. Y., Weigel N. L., Edwards D. P., Tsai M.-J. and O'Malley B. W., Hormone and antihormone induce distinct conformational changes which are central to steroid receptor activation. J. Biol. Chem. 267 (1992) 19513-29520.
22. Scatchard G., The attraction of proteins for small molecules and ions. Ann. N.Y. Acad. Sci. 51 (1949) 660-672.
23. Christensen K., Estes P. A., Onate S. A., Beck C. A., De Marzo A., Altmann M., Lieberman B. A., St. John J., Nordeen S. K. and Edwards D. P., Characterization and functional properties of the A and B forms of human progesterone recep-tors synthesized in a baculovirus system. Mol. Endocrinol. 5 (1991) 1755-1770.
24. Estes P. A., Suba E. J., Lawler-Heavner J., El-ashry D., Wei L. L., Toft D. O., Sullivan W. P., Horwitz K. B. and Edwards D. P., Immunologic analysis of human breast cancer progesterone receptors. I. Immunoaffinity purification of transformed receptors and production of monoclonal antibodies. Biochemistry 26 (1987) 6250-6262.
25. Gray G. O. and Satyaswaroop P. G., Species crossreactivity of human progesterone receptor monoclonal antibodies: Western blot analysis. Biochem. Biophys. Res. Commun. 157 (1988) 1067-1077.
26. Sheridan P. L., Francis M. D. and Horwitz K. B., Synthesis of human progesterone receptors in T47D cells. Nascent A-and B-receptors are active without a phosphorylation-dependent post-translational maturation step. J. Biol. Chem. 264 (1989) 7054-7058.
27. El-Ashry D., Onate S. A., Nordeen S. K. and Edwards D. P., Human progesterone receptor complexed with the antagonist RU 486 binds to hormone response elements in a structurally altered form. Mol. Endocrinol. 3 (1989) 1545-1558.
28. Clemm D. L., Macy B. L., Santiso-Mere D. and McDonnell D. P., Definition of the critical cellular components which distinguish between hormone and antihormone activated progesterone receptor. J. Steroid Biochem. Mol. Biol. 53 (1995) 487-495.
29. Agoulnik I., Weigel N., Tong X.W., Blankenburg K. and Kieback D. G., Genetic mutations in the human progesterone receptor gene associated with increased cancer risk lead to a structurally and functionally altered receptor protein. 87th Annual Meeting of the American Association for Cancer Research, Washington DC, 1996, pp. 222 (Abstract).
30. Yang N. N., Venugopalan M., Hardikar S. and Glasebrook A., Identification of an estrogen response element activated by metabolites of 17β-estradiol and raloxifene. Science 273 (1996) 1222-1225.
31. Bocquel M. T., Ji J., Ylikomi T., Benhamou B., Vergezac A., Chambon P. and Gronemeyer H., Type II antagonists impair the DNA binding of steroid hormone receptors without affecting dimerization. J. Steroid Biochem. Mol. Biol. 45 (1993) 205-215.
32. Delabre K., Guiochon-Mantel A. and Milgrom E., In vivo evidence against the existence of antiprogestins disrupting recptor binding to DNA. Proc. Natl. Acad. Sci. U.S.A. 90 (1993) 4421-4425.
33. Ferguson E. R. and Katzenellenbogen B. S., A comparative study of antiestrogen action: temporal patterns of antagonism of estrogen stimulated uterine growth and effects on estrogen receptor levels. Endocrinology 100 (1977) 1242-1251.
34. Tasset D., Tora L., Fromental C., Scheer E. and Chambon P., Distinct classes of transcriptional activating domains function by different mechanisms. Cell 62 (1990) 1177-1187.
35. Schreihofer, D. A., Pace, C., Friend, K. E. and Shupnik, M. A., Transcriptional activation by TERP-1, a naturally occurring rat estrogen receptor variant. 10th International Congress of Endocrinology, San Francisco, 1996, OR51-7 (Abstract).
36. Katzenellenbogen J. A., O'Malley B. W. and Katzenellenbogen B. S., Tripartite steroid hormone receptor pharmacology; interaction with multiple effector sites as a basis for the cell-and promoter-specific action of these hormones. Mol. Endocrinol. 10 (1996) 119-131.